Challenges to the early diagnosis and treatment of breast cancer in developing countries
Top Cited Papers
Open Access
- 1 January 2014
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Oncology
- Vol. 5 (3), 465-477
- https://doi.org/10.5306/wjco.v5.i3.465
Abstract
This critical review of the literature assembles and compares available data on breast cancer clinical stage, time intervals to care, and access barriers in different countries. It provides evidence that while more than 70% of breast cancer patients in most high-income countries are diagnosed in stages I and II, only 20%-50% patients in the majority of low- and middle-income countries are diagnosed in these earlier stages. Most studies in the developed world show an association between an advanced clinical stage of breast cancer and delays greater than three months between symptom discovery and treatment start. The evidence assembled in this review shows that the median of this interval is 30-48 d in high-income countries but 3-8 mo in low- and middle-income countries. The longest delays occur between the first medical consultation and the beginning of treatment, known as the provider interval. The little available evidence suggests that access barriers and quality deficiencies in cancer care are determinants of provider delay in low- and middle-income countries. Research on specific access barriers and deficiencies in quality of care for the early diagnosis and treatment of breast cancer is practically non-existent in these countries, where it is the most needed for the design of cost-effective public policies that strengthen health systems to tackle this expensive and deadly disease.Keywords
This publication has 113 references indexed in Scilit:
- Trends in Breast Cancer Incidence Rates by Age and Stage at Diagnosis in Gharbiah, Egypt, over 10 Years (1999–2008)Journal of Cancer Epidemiology, 2013
- The Haiti Breast Cancer Initiative: Initial Findings and Analysis of Barriers-to-Care Delaying Patient PresentationJournal of Oncology, 2013
- The Aarhus statement: improving design and reporting of studies on early cancer diagnosisBritish Journal of Cancer, 2012
- Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010The Lancet Oncology, 2011
- Auditing the diagnosis of cancer in primary care: the experience in ScotlandBritish Journal of Cancer, 2009
- Do diagnostic delays in cancer matter?British Journal of Cancer, 2009
- Delay in diagnosis: the experience in DenmarkBritish Journal of Cancer, 2009
- Assessment of breast cancer opportunistic screening by clinical–pathological indicators: a population-based studyBritish Journal of Cancer, 2009
- Cancer survival in five continents: a worldwide population-based study (CONCORD)The Lancet Oncology, 2008
- Delay versus help seeking for breast cancer symptoms: A critical review of the literature on patient and provider delaySocial Science & Medicine, 1993